"Inflammation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.
Descriptor ID |
D007249
|
MeSH Number(s) |
C23.550.470
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Inflammation".
Below are MeSH descriptors whose meaning is more specific than "Inflammation".
This graph shows the total number of publications written about "Inflammation" by people in this website by year, and whether "Inflammation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 2 | 1 | 3 |
1996 | 0 | 5 | 5 |
1997 | 0 | 3 | 3 |
1998 | 0 | 6 | 6 |
1999 | 2 | 2 | 4 |
2000 | 1 | 4 | 5 |
2001 | 2 | 5 | 7 |
2002 | 5 | 8 | 13 |
2003 | 3 | 12 | 15 |
2004 | 10 | 11 | 21 |
2005 | 10 | 16 | 26 |
2006 | 11 | 24 | 35 |
2007 | 14 | 20 | 34 |
2008 | 7 | 13 | 20 |
2009 | 16 | 15 | 31 |
2010 | 14 | 15 | 29 |
2011 | 26 | 27 | 53 |
2012 | 17 | 29 | 46 |
2013 | 15 | 27 | 42 |
2014 | 20 | 24 | 44 |
2015 | 20 | 26 | 46 |
2016 | 16 | 33 | 49 |
2017 | 20 | 25 | 45 |
2018 | 32 | 30 | 62 |
2019 | 16 | 33 | 49 |
2020 | 28 | 43 | 71 |
2021 | 17 | 45 | 62 |
2022 | 4 | 57 | 61 |
2023 | 1 | 59 | 60 |
2024 | 11 | 19 | 30 |
2025 | 7 | 4 | 11 |
To return to the timeline,
click here.
Below are the most recent publications written about "Inflammation" by people in Profiles.
-
Functional regulation of macrophages by Ces1d-mediated lipid signaling in immunometabolism. Mol Metab. 2025 Jul; 97:102166.
-
Identification of Distinct Biological Groups of Patients With Cryptogenic NORSE via Inflammatory Profiling. Neurol Neuroimmunol Neuroinflamm. 2025 Jul; 12(4):e200403.
-
Understanding the Role of Adipokines in Cardiometabolic Dysfunction: A Review of Current Knowledge. Biomolecules. 2025 Apr 23; 15(5).
-
Inflammatory and clinical risk factors for asthma attacks (ORACLE2): a patient-level meta-analysis of control groups of 22 randomised trials. Lancet Respir Med. 2025 Jun; 13(6):505-516.
-
Glucose uptake in pigment glia suppresses Tau-induced inflammation and photoreceptor degeneration. Dis Model Mech. 2025 Apr 01; 18(4).
-
Integration of lipidomics with targeted, single cell, and spatial transcriptomics defines an unresolved pro-inflammatory state in colon cancer. Gut. 2025 Mar 06; 74(4):586-602.
-
Evolving concepts of low-density lipoprotein: From structure to function. Eur J Clin Invest. 2025 May; 55(5):e70019.
-
Dupilumab reduces acute exacerbations and improves lung function in patients with COPD with type 2 inflammation irrespective of body mass index, airflow obstruction, dyspnea, and exercise capacity index scores. Respir Med. 2025 May; 241:108015.
-
Neonatal Inflammation and Feeding Disorders at 1?Year in Infants With Congenital Gastrointestinal Malformations. Acta Paediatr. 2025 Jul; 114(7):1702-1708.
-
Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials. Lancet Respir Med. 2025 Mar; 13(3):234-243.